日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up

类风湿性关节炎患者在3年随访期间对依那西普治疗的依从性

Vogelzang, E H; Hebing, R C F; Nurmohamed, M T; van Kuijk, A W R; Kruijff, J W F; l'Ami, M J; Krieckaert, C L M; Wolbink, G

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade

类风湿性关节炎患者滑膜中 TWEAK 及其受体 Fn14 的表达与银屑病关节炎患者滑膜中的表达及其对肿瘤坏死因子阻断的反应

van Kuijk, A W R; Wijbrandts, C A; Vinkenoog, M; Zheng, T S; Reedquist, K A; Tak, P P

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue

一项前瞻性、随机、安慰剂对照研究,旨在识别与银屑病关节炎积极治疗相关的生物标志物:阿达木单抗治疗对滑膜组织的影响

van Kuijk, A W R; Gerlag, D M; Vos, K; Wolbink, G; de Groot, M; de Rie, M A; Zwinderman, A H; Dijkmans, B A C; Tak, P P

Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

对银屑病关节炎患者滑膜中细胞浸润和滑膜炎症及关节破坏介质表达的详细分析:对治疗的启示

van Kuijk A W R, Reinders-Blankert P, Smeets T J M, Dijkmans B A C, Tak P P

A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis

一项随机、双盲、安慰剂对照、多中心试验,研究甲氨蝶呤联合环孢素治疗活动性银屑病关节炎患者的疗效

Fraser, A D; van Kuijk, A W R; Westhovens, R; Karim, Z; Wakefield, R; Gerards, A H; Landewé, R; Steinfeld, S D; Emery, P; Dijkmans, B A C; Veale, D J